−Removed: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
−Removed: Our common stock is
−Removed: currently listed on the Nasdaq Capital Market under the symbol “MODD.”
−Removed: On May 31, 2022, we had approximately 80
+Added: MARKET FOR REGISTRANT’S COMMON EQUITY,
+Added: RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
+Added: Market Information
+Added: for Common Stock
+Added: Our common stock is currently listed on the Nasdaq Capital
+Added: Market under the symbol “MODD.”
+Added: Holders of Record
+Added: As of March 31, 2023, we had approximately
70 stockholders of record.
−Removed: The actual number of stockholders
−Removed: is greater than this number of stockholders of record and includes stockholders who are beneficial owners but whose shares are held in
−Removed: street name by brokers and other nominees.
−Removed: This number of stockholders of record also does not include stockholders whose shares may
−Removed: be held in trust by other entities.
−Removed: We have never declared
−Removed: or paid any cash dividend on our capital stock.
−Removed: We do not anticipate paying any cash dividends in the foreseeable future and we intend
−Removed: to retain all of our earnings, if any, to finance our growth and operations and to fund the expansion of our business.
−Removed: Payment of any
−Removed: dividends will be made in the discretion of our board of directors, after its taking into account various factors, including our financial
−Removed: condition, operating results, current and anticipated cash needs and plans for expansion.
−Removed: Any dividends that may be declared or paid
−Removed: on our common stock, must also be paid in the same consideration or manner, as the case may be, on our shares of preferred stock, if
−Removed: Sales of Unregistered Securities
−Removed: forth below is information regarding shares of Common Stock, convertible notes and warrants issued, and options granted, by us within
−Removed: the past three years that were not registered under the Securities Act.
−Removed: Also included is the consideration, if any, received by us for
−Removed: such shares, convertible notes, warrants and options, and information relating to the section of the Securities Act, or rule of the Securities
−Removed: and Exchange Commission, under which exemption from registration was claimed.
−Removed: March 31, 2022, we issued 15,250 shares of our Common Stock to non-employee members of our board of directors for service as directors
−Removed: in accordance with our Outside Director Compensation Plan (the “Director Plan”).
−Removed: On December 31, 2021, we issued 5,775 shares
−Removed: of our Common Stock to non-employee members of our board of directors for service as directors in accordance with the Director Plan.
−Removed: On September 30, 2021, we issued 3,636 shares of our Common Stock to non-employee members of our board of directors for service as directors
−Removed: in accordance with the Director Plan.
−Removed: On June 30, 2021, we issued 1,836 shares of our Common Stock to non-employee members of our board
−Removed: of directors for service as directors in accordance with our Outside Director Compensation Plan the Director Plan.
−Removed: March 23, 2022 we issued 45,000 shares of our Common Stock to a service provider.
−Removed: On January 5, 2022, we issued 16,666 shares of our
−Removed: Common Stock to service providers.
−Removed: In 2021, we issued a total of 52,834 shares of our Common Stock
−Removed: to five service providers in exchange for services rendered.
−Removed: In 2019, we issued 10,000 shares of our Common Stock for cash to a service
−Removed: Purchases of Common Stock
−Removed: October 28, 2021, we sold to two of our executive officers a total of 30,865 shares of our Common Stock at a purchase price of $8.10
−Removed: per share, which resulted in gross proceeds to us of approximately $250,000.
−Removed: February and May 2021, we issued to accredited investors in a private placement $6,610,550 aggregate principal amount of our 12% unsecured
−Removed: convertible promissory notes, due 12 months from each respective issuance date, at par and warrants to purchase in the aggregate 767,796
−Removed: shares of our Common Stock at an exercise price of $24.00 per share, exercisable for a 5-year period, as provided in such warrants.
−Removed: March and December 2020, we sold to accredited investors in a private placement a total of 320,796 shares of our Common Stock at a purchase
−Removed: price of $8.61 per share.
−Removed: The 2020 Placement resulted in gross proceeds to us of $2,762,054.
−Removed: November 2018 and March 2019, we sold to accredited investors in a private placement a total of 618,996 shares of our Common Stock at
−Removed: a purchase price of $6.75 per share, resulting in gross proceeds to us of $4,142,666.
−Removed: The above sales
−Removed: of our securities were made pursuant to exemptions from registration pursuant to Section 4(2) and/or Rule 506 of Regulation D of the
−Removed: Securities Act.
−Removed: We made such determinations based upon representations by the purchasers of such securities including, without limitation,
−Removed: that such purchasers were “accredited investors” as defined in the Securities Act.
+Added: The actual number of stockholders is greater than this number of stockholders of record and includes stockholders
+Added: who are beneficial owners but whose shares are held in street name by brokers and other nominees.
+Added: This number of stockholders of record
+Added: also does not include stockholders whose shares may be held in trust by other entities.
+Added: Securities Authorized for Issuance
+Added: under Equity Compensation Plan
+Added: For information regarding securities authorized
+Added: for issuance under equity compensation plans, please refer to Item 12, Security Ownership of Certain Beneficial Owners and Management
+Added: and Related Stockholder Matters .
+Added: Dividend Policy
+Added: We have never declared or paid any
+Added: cash dividend on our capital stock.
+Added: We do not anticipate paying any cash dividends in the foreseeable future and we intend to retain all
+Added: of our earnings, if any, to finance our growth and operations and to fund the expansion of our business.
+Added: Payment of any dividends will
+Added: be made in the discretion of our board of directors, after taking into account various factors, including our financial condition, operating
+Added: results, current and anticipated cash needs and plans for expansion.
+Added: Any dividends that may be declared or paid on our common stock, must
+Added: also be paid in the same consideration or manner, as the case may be, on our shares of preferred stock, if any.
+Added: Recent Sales of Unregistered Securities
+Added: Set forth below is information regarding
+Added: securities issued by us within the past three years that were not registered under the Securities Act.
+Added: Also included is the consideration,
+Added: if any, received by us for such issuances, and information relating to the section of the Securities Act, or rule of the Securities and
+Added: Exchange Commission, under which exemption from registration was claimed.
+Added: Director Compensation
+Added: On each of March 31, 2023, December 30, 2022,
+Added: and September 30, 2022 we issued 6,375 shares of our common stock to four of our non-employee directors in accordance with our Outside
+Added: Director Compensation Plan (the “Director Plan”).
+Added: On August 8, 2022, we issued 5,000 shares of our common stock to two of
+Added: our non-employee directors in accordance with the Director Plan.
+Added: On June 30, 2022, we issued 2,664 shares of our common stock to two of
+Added: our non-employee directors in accordance with the Director Plan.
+Added: On March 31, 2022, we issued 15,250 shares of our common stock to
+Added: four of our non-employee members of our board of directors in accordance with the Director Plan.
+Added: On December 31, 2021, we issued 5,775
+Added: shares of our common stock to four of our non-employee members of our board of directors in accordance with the Director Plan.
+Added: 30, 2021, we issued 3,636 shares of our common stock to four of our non-employee directors in accordance with the Director Plan.
+Added: 30, 2021, we issued 1,836 shares of our common stock to four of our non-employee directors in accordance with the Director Plan.
+Added: In March 2023, we issued 10,000 shares of our
+Added: common stock to a service provider.
+Added: In March 2023, we issued 478 shares of our common stock to a service provider.
+Added: In February 2023, we
+Added: issued 438 shares of our common stock to a service provider.
+Added: In May 2022, we issued 348 shares of our common stock to a service provider.
+Added: In March 2022, we issued 45,000 shares of our Common Stock to a service provider.
+Added: In January 2022, we issued 16,666 shares of our common
+Added: stock to service providers.
+Added: In October 2021, we issued 8,334 shares of our common stock to service providers.
+Added: In April 2021, we issued
+Added: 20,000 shares of our common stock to a service provider.
+Added: In May 2022, we issued warrants in a private placement
+Added: to purchase an aggregate of 1,438,202 shares of common stock at an exercise price of $6.60 per share.
+Added: The warrants were exercisable six
+Added: months from the date of issuance and have a five-year term from the date the warrants become exercisable.
+Added: Officer Purchases of Common Stock
+Added: In October 2021, we sold to two of our executive
+Added: officers a total of 30,864 shares of our common stock at a purchase price of $8.10 per share, which resulted in gross proceeds to us of
+Added: 2021 Placement
+Added: Between February and May 2021, we issued
+Added: to accredited investors in a private placement $6,610,550 aggregate principal amount of our 12% unsecured convertible promissory notes,
+Added: due 12 months from each respective issuance date, at par and warrants to purchase in the aggregate 761,912 shares of our common stock
+Added: at an exercise price of $24.00 per share, exercisable for a 5-year period, as provided in such warrants.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.